دورية أكاديمية

Analyzing noncovalent interactions between notoginseng saponins and lysozyme by deposition scanning intensity fading MALDI-TOF mass spectrometry.

التفاصيل البيبلوغرافية
العنوان: Analyzing noncovalent interactions between notoginseng saponins and lysozyme by deposition scanning intensity fading MALDI-TOF mass spectrometry.
المؤلفون: Zhao X; Key Laboratory for Applied Technology of Sophisticated Analytical Instruments, Shandong Analysis and Test Centre, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China., Ren J; Department of Pharmaceutical Science, Zunyi Medical University at Zhuhai Campus, Zhuhai, China., Wang Z; Department of Pharmaceutical Science, Zunyi Medical University at Zhuhai Campus, Zhuhai, China., Chen X; Key Laboratory for Applied Technology of Sophisticated Analytical Instruments, Shandong Analysis and Test Centre, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
المصدر: Journal of mass spectrometry : JMS [J Mass Spectrom] 2024 Jul; Vol. 59 (7), pp. e5058.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9504818 Publication Model: Print Cited Medium: Internet ISSN: 1096-9888 (Electronic) Linking ISSN: 10765174 NLM ISO Abbreviation: J Mass Spectrom Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Chichester, UK : Wiley, c1995-
مواضيع طبية MeSH: Muramidase*/chemistry , Muramidase*/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*/methods , Saponins*/chemistry , Saponins*/analysis , Saponins*/metabolism , Panax notoginseng*/chemistry, Protein Binding ; Molecular Docking Simulation ; Reproducibility of Results ; Animals ; Trisaccharides
مستخلص: Analysis of noncovalent interactions between natural products and proteins is important for rapid screening of active ingredients and understanding their pharmacological activities. In this work, the intensity fading MALDI-TOF mass spectrometry (IF-MALDI-MS) method with improved reproducibility was implemented to investigate the binding interactions between saponins from Panax notoginseng and lysozyme. The benchmark IF-MALDI-MS experiment was established using N,N',N″-triacetylchitotriose-lysozyme as a model system. The reproducibility of ion intensities in IF-MALDI-MS was improved by scanning the whole sample deposition with a focused laser beam. The relative standard deviation (RSD) of deposition scanning IF-MALDI-MS is 5.7%. Similar decay trends of the relative intensities of notoginseng saponins against increasing amounts of lysozyme were observed for all six notoginseng saponins. The half-maximal fading concentration (FC 50 ) was calculated to quantitatively characterize the binding affinity of each ligand based on the decay curve. According to the FC 50 values obtained, the binding affinities of the six notoginseng saponins were evaluated in the following order: notoginsenoside S > notoginsenoside Fc > ginsenoside Rb1 > ginsenoside Rd > notoginsenoside Ft1 > ginsenoside Rg1. The binding order was in accordance with molecular docking studies, which showed hydrogen bonding might play a key role in stabilizing the binding interaction. Our results demonstrated that deposition scanning IF-MALDI-MS can provide valuable information on the noncovalent interactions between ligands and proteins.
(© 2024 John Wiley & Sons Ltd.)
References: Zhou P, Huang J, Tian F. Specific noncovalent interactions at protein‐ligand interface: implications for rational drug design. Curr Med Chem. 2012;19(2):226‐238. doi:10.2174/092986712803414150.
Pichler WJ. The important role of non‐covalent drug‐protein interactions in drug hypersensitivity reactions. Allergy. 2022;77(2):404‐415. doi:10.1111/all.14962.
Davoine C, Pochet L, Fillet M. Advances in analytical technologies detecting and characterizing noncovalent interactions for fragment‐based drug discovery. Trac‐Trends in Anal Chem. 2023;166:117161. doi:10.1016/j.trac.2023.117161.
Daniel JM, Friess SD, Rajagopalan S, Wendt S, Zenobi R. Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry. Int J Mass Spectrom. 2002;216(1):1‐27. doi:10.1016/S1387‐3806(02)00585‐7.
Du Y, Zhao FJ, Xing JP, Cui M, Liu ZQ. Investigation of labile protein‐ligand interactions by native electrospray ionization mass spectrometry. Int J Mass Spectrom. 2021;462:116524. doi:10.1016/j.ijms.2021.116524.
Hofstadler SA, Sannes‐Lowery KA. Applications of ESI‐MS in drug discovery: interrogation of noncovalent complexes. Nat Rev Drug Discov. 2006;5(7):585‐595. doi:10.1038/nrd2083.
Jecklin MC, Touboul D, Bovet C, Wortmann A, Zenobi R. Which electrospray‐based ionization method best reflects protein‐ligand interactions found in solution? A comparison of ESI, nanoESI, and ESSI for the determination of dissociation constants with mass spectrometry. J Am Soc Mass Spectrom. 2008;19(3):332‐343. doi:10.1016/j.jasms.2007.11.007.
Schmidt C, Robinson CV. Dynamic protein ligand interactions—Insights from MS. FEBS J. 2014;281(8):1950‐1964. doi:10.1111/febs.12707.
Yanes O, Nazabal A, Wenzel R, Zenobi R, Aviles FX. Detection of noncovalent complexes in biological samples by intensity fading and high‐mass detection MALDI‐TOF mass spectrometry. J Proteome Res. 2006;5(10):2711‐2719. doi:10.1021/pr060202f.
Maedler S, Erba EB, Zenobi R. MALDI‐ToF mass spectrometry for studying noncovalent complexes of biomolecules. In: Cai Z, Liu S, eds. Applications of Maldi‐Tof Spectroscopy. Vol.331; 2013:1‐36.
Yanes Ó, Villanueva J, Querol E, Aviles FX. Intensity‐fading MALDI‐TOF‐MS: novel screening for ligand binding and drug discovery. Drug Discovery Today: TARGETS. 2004;3(2):23‐30. doi:10.1016/S1741‐8372(04)02417‐X.
Wu N, Jiao L, Bütikofer M, Zeng Z, Zenobi R. High‐mass matrix‐assisted laser desorption/ionization mass spectrometry for absolute quantitation of noncovalent protein–protein binding interactions. Anal Chem. 2021;93(31):10982‐10989. doi:10.1021/acs.analchem.1c02126.
Stojko J, Dupin A, Chaignepain S, et al. Structural characterization of the yeast CF IA complex through a combination of mass spectrometry approaches. Int J Mass Spectrom. 2017;420:57‐66. doi:10.1016/j.ijms.2016.08.005.
Wu N, Olechwier AM, Brunner C, et al. High‐mass MALDI‐MS unravels ligand‐mediated G protein–coupling selectivity to GPCRs. Proc Natl Acad Sci. 2021;118(31):e2024146118. doi:10.1073/pnas.2024146118.
Villanueva J, Yanes O, Querol E, Serrano L, Aviles FX. Identification of protein ligands in complex biological samples using intensity‐fading MALDI‐TOF mass spectrometry. Anal Chem. 2003;75(14):3385‐3395. doi:10.1021/ac020644k.
Downard KM. Indirect study of non‐covalent protein complexes by MALDI mass spectrometry: origins, advantages, and applications of the “intensity‐fading” approach. Mass Spectrom Rev. 2016;35(5):559‐573. doi:10.1002/mas.21480.
Yanes O, Villanueva J, Querol E, Aviles FX. Detection of non‐covalent protein interactions by ‘intensity fading’ MALDI‐TOF mass spectrometry: applications to proteases and protease inhibitors. Nat Protoc. 2007;2(1):119‐130. doi:10.1038/nprot.2006.487.
Yanes O, Villanueva J, Querol E, Aviles FX. Functional screening of serine protease inhibitors in the medical leech Hirudo medicinalis monitored by intensity fading MALDI‐TOF MS. Mol Cell Proteomics. 2005;4(10):1602‐1613. doi:10.1074/mcp.M500145‐MCP200.
Ma L, Wang Z, Liu S, Song F, Liu Z, Liu S. Screening calmodulin‐binding ligands using intensity‐fading matrix‐assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 2013;27(13):1527‐1534. doi:10.1002/rcm.6594.
Wang Z, Yu X, Cui M, Liu Z, Song F, Liu S. Investigation of calmodulin‐peptide interactions using matrix‐assisted laser desorption/ionization mass spectrometry. J am Soc Mass Spectrom. 2009;20(4):576‐583. doi:10.1016/j.jasms.2008.11.017.
Du Y, Du Y, Cui M, Liu Z. Characterization of the noncovalent interactions between lysozyme and Panaxadiol glycosides by intensity‐fading–matrix‐assisted laser desorption ionization–mass spectrometry (IF‐MALDI‐MS). Analytical Letters. 2021;54(15):2387‐2394. doi:10.1080/00032719.2020.1867995.
Covaleda G, Trejo SA, Salas‐Sarduy E, Alonso del Rivero M, Angeles Chavez M, Aviles FX. Intensity fading MALDI‐TOF mass spectrometry and functional proteomics assignments to identify protease inhibitors in marine invertebrates. J Proteomics. 2017;165:75‐92. doi:10.1016/j.jprot.2017.05.027.
Wu L, Zhang W, Tang YH, et al. Effect of total saponins of “Panax notoginseng root” on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. Phytomed Int J Phytotherapy Phytopharmacol. 2010;17(3–4):233‐240. doi:10.1016/j.phymed.2009.07.021.
Yang X, Xiong X, Wang H, Wang J. Protective effects of Panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies. Evid Based Complement Alternat Med. 2014;2014:204840. doi:10.1155/2014/204840.
Yang F, Ma Q, Matsabisa MG, Chabalala H, Braga FC, Tang M. Panax notoginseng for cerebral ischemia: a systematic review. Am J Chin Med. 2020;48(6):1331‐1351. doi:10.1142/S0192415X20500652.
Shim JS, Song M‐Y, Yim S‐V, Lee S‐E, Park K‐S. Global analysis of ginsenoside Rg1 protective effects in β‐amyloid‐treated neuronal cells. J Ginseng Res. 2017;41(4):566‐571. doi:10.1016/j.jgr.2016.12.003.
Kim J‐H. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res. 2018;42(3):264‐269. doi:10.1016/j.jgr.2017.10.004.
Lee CH, Kim J‐H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res. 2014;38(3):161‐166. doi:10.1016/j.jgr.2014.03.001.
Huang Y, Cui L, Yang H, et al. Lysozyme improves the inhibitory effects of Panax notoginseng saponins on phenotype transformation of vascular smooth muscle cells by binding to Ginsenoside Re. Front Nutr. 2021;8:795888. doi:10.3389/fnut.2021.795888.
Cheetham JC, Artymiuk PJ, Phillips DC. Refinement of an enzyme complex with inhibitor bound at partial occupancy: hen egg‐white lysozyme and tri‐N‐acetylchitotriose at 1.75 Å resolution. J Mol Biol. 1992;224(3):613‐628. doi:10.1016/0022‐2836(92)90548‐X.
Naïm M, Bhat S, Rankin KN, et al. Solvated interaction energy (SIE) for scoring protein‐ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Model. 2007;47(1):122‐133. doi:10.1021/ci600406v.
Clark SM, Konermann L. Screening for noncovalent ligand−receptor interactions by electrospray ionization mass spectrometry‐based diffusion measurements. Anal Chem. 2004;76(5):1257‐1263. doi:10.1021/ac035230l.
Holle A, Haase A, Kayser M, Höhndorf J. Optimizing UV laser focus profiles for improved MALDI performance. J Mass Spectrom JMS. 2006;41(6):705‐716. doi:10.1002/jms.1041.
Yanes O, Aviles FX, Roepstorff P, Jorgensen TJD. Exploring the “intensity fading” phenomenon in the study of noncovalent interactions by MALDI‐TOF mass spectrometry. J Am Soc Mass Spectrom. 2007;18(2):359‐367. doi:10.1016/j.jasms.2006.10.001.
Tang J, Fu Q, Cui M, Xing J, Liu Z, Liu S. Study of the non‐covalent interactions of ginsenosides and lysozyme using electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2015;29(21):2031‐2038. doi:10.1002/rcm.7366.
Qu C, Yu S, Bai A, Wang J. Study on the interactions between ginsenosides and lysozyme under acidic condition by ESI‐MS and molecular docking. Spectrochim Acta Part a‐Molec Biomol Spectrosc. 2011;78(2):676‐680. doi:10.1016/j.saa.2010.11.047.
معلومات مُعتمدة: 81860617 National Natural Science Foundation of China; 22074071 National Natural Science Foundation of China; 32360117 National Natural Science Foundation of China; tsqn202103099 Program for Taishan Scholars of Shandong Province; QKH-J[2020]1Y045 Guizhou Provincial Natural Science Foundation; 2021GXRC090 Jinan University and Institute Innovation Team Project
فهرسة مساهمة: Keywords: MALDI‐MS; Panax notoginseng; intensity fading; lysozyme; molecular docking; noncovalent interaction
المشرفين على المادة: EC 3.2.1.17 (Muramidase)
0 (Saponins)
38864-21-0 (N,N',N''-triacetylchitotriose)
0 (Trisaccharides)
تواريخ الأحداث: Date Created: 20240606 Date Completed: 20240606 Latest Revision: 20240617
رمز التحديث: 20240617
DOI: 10.1002/jms.5058
PMID: 38842112
قاعدة البيانات: MEDLINE
الوصف
تدمد:1096-9888
DOI:10.1002/jms.5058